Bank of New York Mellon Corp - TAYSHA GENE THERAPIES INC ownership

TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 53 filers reported holding TAYSHA GENE THERAPIES INC in Q4 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of TAYSHA GENE THERAPIES INC
ValueSharesWeighting
Q2 2024$1,018,000
+889.2%
454,464
+681.7%
0.00%
Q4 2023$102,908
+24.9%
58,140
+123.0%
0.00%
Q3 2023$82,394
+274.5%
26,074
+130.8%
0.00%
Q3 2022$22,000
-50.0%
11,295
-3.2%
0.00%
Q2 2022$44,000
-91.4%
11,670
-85.1%
0.00%
Q1 2022$510,000
-42.5%
78,237
+2.7%
0.00%
Q4 2021$887,000
-35.4%
76,170
+3.3%
0.00%
Q3 2021$1,373,000
+14.2%
73,745
+30.1%
0.00%
Q2 2021$1,202,000
+120.1%
56,672
+110.4%
0.00%
Q1 2021$546,000
-23.7%
26,932
-0.2%
0.00%
Q4 2020$716,00026,9800.00%
Other shareholders
TAYSHA GENE THERAPIES INC shareholders Q4 2022
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 2,330,937$5,221,2994.40%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 3,700,000$8,288,0001.68%
Octagon Capital Advisors LP 4,572,222$10,241,7771.61%
VR Adviser, LLC 9,000,000$20,160,0001.28%
Ghost Tree Capital, LLC 1,250,000$2,800,0000.88%
RTW INVESTMENTS, LP 18,800,299$42,112,6700.65%
Diametric Capital, LP 512,361$1,147,6880.62%
Quantum Private Wealth, LLC 730,520$1,636,3650.58%
Avoro Capital Advisors LLC 18,650,000$41,776,0000.56%
Sands Capital Ventures, LLC 724,873$1,623,7160.54%
View complete list of TAYSHA GENE THERAPIES INC shareholders